|
Invited Lectures (last 5 years)
- Séminaire Merck Frosst en Néphrologie et
Pharmacologie Cardiovasculaire, Hôtel Dieu de Québec,
February 2, 2001, Titre. " Rôle du monoxyde d'azote
et du peroxynitrite dans le développement de l'insulino-résistance
associée à l'obésité".
- "VIIIth International Symposium on Insulin Receptors
and Insulin Action" Geneva, Switzerland, May 8, 2001
Titre. "Nutrient signaling by the mTOR pathway causes
insulin resistance in myocytes ".
- "61st American Diabetes Association meeting"
Session on : Signaling Insight from Transgenic Models.
Philadelphia, USA, June 26, 2001 Titre. "The Protein
Tyrosine Phosphatase SHP-1 Is Expressed in Skeletal Muscle
and Negatively Modulates Insulin-Stimulated Glucose Disposal
in Mice ".
- Research Seminar Series. The Ottawa Health Center, Ottawa,
Canada. December 13, 2001 Title. " "iNOS : an
inflammatory mediator of insulin resistance in obesity"
.
- Research Seminar Series. Depart. Of Pharmacology, University
of Montreal, Montreal Canada. January 24, 2002 Title. "
iNOS : un médiateur inflammatoire de la résistance
à l'insuline associée à l'obésité".
- Graduate Student seminar series. Department of Biochemistry,
Microbiology and Immunology, Faculty of Medicine, University
of Ottawa, February 7, 2002 Title. " A novel role for
iNOS in the development of insulin resistance in obesity
and other inflammatory settings".
- Abbott Laboratories, Abbott Park, IL, USA, February 20,
2002 Titre. "Novel modulators of insulin action in
muscle and adipose cells".
- Research Seminar series. Department of Nutrition, Case
Western Reserve University, Cleveland Ohio. March 22, 2002.
Titre. " Titre. "iNOS : a key mediator of muscle
insulin resistance in obesity".
- CFBS meeting, Symposium on « Bioenergetics
and Obesity », Montréal, Québec,
June 13, 2002. Title : « Obesity-linked
muscle insulin resistance and its treatment with nutraceutics ».
- 9th International meeting on Obesity, Mini-Symposim on
« Endocrine function of adipose tissue »,
Sao Paulo, Brazil, August 24-29, 2002. Title : « Adipocyte-derived
NO : regulation and biological role ».
- Annual meeting of the Canadian Diabetes Association,
Vancouver, Canada, October 2-5, 2002. Title : « The
role of NO in insulin-target tissues ».
- SQBC meeting, Symposium on « Apoptose, Stress
oxydant, et Inflammation », Québec, 23-25 octobre,
2002. Title : « Le monoxyde d'azote (NO):
une arme a deux tranchants dans la pathogénèse
du diabète ».
- Research Seminar series. CHUM, Université de Montréal,
17 décembre 22, 2002. Invité par le Dr Marc
Prentki, Titre :".Nouveaux régulateurs
du transport du glucose dans les cellules musculaires
- Endocrine Rounds, Mount-Sinai Hospital, Toronto, Mars
2003 Title. Insulin resistance in obesity : the inflammatory
link. (Invited by Dr Adria Giacca)
- "Annual symposium of the Société Québecoise
de Lipidologie" Château Bonne Entente, Québec,
24-26 avril 2003, Title. "Obésité et
insulino-résistance : qu’avons nous appris
des modèles animaux transgéniques?"
- 9th Nestlé Nutrition Workshop "Metabolic
Issues of Clinical Nutrition" Bangkok, Thailand: 16-20
November 2003 Title : Cytokines and obesity-linked
insulin resistance and its prevention by dietary fish proteins.
- Centre de recherche de l'Hôpital Sainte-Justine
CHUM, Université de Montréal, February 13,
2004. Invited by Dr Émile Levy, Titre :"AMPK:
Une nouvelle arme pour contrer les médiateurs inflammatoires
de l'insulino-résistance ».
- Centre for Research in Biopharmaceuticals, University
of Ottawa, Invited by Drs Jean-Marc Renaud and Claude Messier,
18 février 2004, Titre : Molecular mechanisms
of insulin- and exercise-induced glucose transport in muscle
and their alterations in insulin-resistant states.
- Introduction Lecture, Chair, Session : Role of Cytokines
in Diabetes and Insulin Resistance Keystone symposium, Banff,
March 9 2004, invited by Dr Michael Czech
- Congrès annuel de l’EPPE, Univ. de Sherbrooke,
invitation du Dr Nicole Gallo- Payet. 5Avril 2004. Titre :
AMPK : une nouvelle cible thérapeutique pour
le traitement des maladies pro-inflammatoires associées
à l’induction de iNOS.
- Congrès annuel de la SQLNM, Québec, 30
avril 2005. Chair : Introduction lecture. Titre :
Le stress oxydatif : ROS vs RNS ou l'évolution des
espècesSQLNM
- Ottawa Health Institute, Invited by Dr. Alexander Sorisky,
Ottawa, 21 sept. 2004. Title : mTOR : from a targt
of a bacterial product to a target of anti-diabetic drugs.
- Séminaire du GRSNA, Université de Montréal.Invité
par Dr. Pierre Moreau, 27 septembre 2004. Titre : Implication
de la voie mTOR/S6K1 dans la pathogénèse de
la résistance à l’insuline
- McGill University Cancer Institute, invited by Dr. Nahum
Sonenberg, July 2, 2004. Title : Implication of the
mTOR pathway in the pathogenesis of insulin resistance.
- Karolinska Institute, Stockholm, Sweden, invited by Dr.
Juleen Zierath, Dec 10, 2004. Title : iNOS inhibition
by AMPK : a novel anti-inflammatory pathway to alleviate
insulin resistance
- McGill University, invited by Dr. Simon Wing, Director,
Division of Endocrinology and Metabolism. Feb. 2, 2005.
Title : iNOS: The molecular link between inflammation
and insulin resistance.
- McGill University, invited by Dr. Michel L. Tremblay,
Director McGill Cancer Centre, March 4, 2005. Title :
Mediators of insulin resistance in altered metabolic states.
- 4th Stock Conference of the International Association
for the Study of Obesity, , Topic : Inflammation and
Obesity,Session : Networks common to immune and metabolic
regulation Title : iNOS vs AMPK : balancing immune
and metabolic regulation in the obese insulin-resistant
state. March 20-24 2005, Istanbul, Turkey.
- "65th American Diabetes Association meeting",
Symposium entitled ‘Endothelial Dysfunction-The Cart
of the Horse for Insulin Resistance’., San Diego,
CA, USA, June 11, 2005, Title. "Nitric Oxide and Insulin
Action - When a Good Thing becomes Too Much of a Good Thing."
- CFBS meeting, Symposium on « Metabolic Dysregulation
in Obesity and Type 2 Diabetes », Guelph, ON,
June 24, 2005. Title : « iNOS : an autocrine/paracrine
inflammatory mediator of insulin resistance in obesity ».
- 2005 NAASO meeting on Obesity, Vancouver, Canada, Oct.
15-19, 2005. Title : « Role of the mTOR/S6K1
pathway in obesity-driven insulin resistance »
- CDA CDA/CSEM Professional Conference and Annual Meetings,
Edmonton. Alberta, October 19-22,2005. Young Scientist Award
lecture.
Organisation of symposiums and international meetings
- Co-organizer of the Forum des jeunes chercheurs de la
société française de biochimie et biologie
moléculaire. (Université Laval, June 1998).
- Co-organizer (Université Laval representant) of
the First congress of the Quebec Foundation for the study
of NO (Institut de Recherche Clinique de Montréal,
November 6 1998).
- Co-organizer of the International congress "Recent
advances in adipose tissue biology and their implications
for obesity" of the Donald Brown research Chair for
Obesity Research, (Université Laval, November 1999).
- Co-organizer (Université Laval representant) of
the Second congress of the Quebec Foundation for the study
of NO (Institut de Recherche Clinique de Montréal,
November 30, 1999).
- Co-organiser of the International congress "The
complications of obesity : the inflammatory link"
of the Donald Brown research Chair for Obesity Research,
(Université Laval, November 2002).
|
|
